Retrospective Study of Suture Tape for Soft Tissue Reconstruction in Patients Suffering From Lateral Ankle Instability
Launched by STRYKER TRAUMA AND EXTREMITIES · Feb 11, 2025
Trial Information
Current as of July 09, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients between and including the age of 14-75 at the time of surgery
- • Patients who were diagnosed with lateral ankle instability by physician clinical assessment
- • Patients who underwent an ATFL repair with Arthrex InternalBrace augmentation device (does not require an isolated repair)
- Exclusion Criteria:
- • Significant secondary procedures done at the time of repair, including significant osteochondral lesions and/or significant microfracture of the talus or tibia that warrant modifying the typical lateral ligament repair post-op rehab protocol. (Minor microfractures and OCD lesions that do not warrant bone debridements, synovectomies, and bone spur removals are allowed)
- • Any concomitant orthopedic procedure that will extend the post-op rehabilitation (e.g., casting/immobilization) beyond the routinely prescribed rehab protocol following an ATFL reconstructive procedure.
- • Patients undergoing a Calcaneal osteotomy
- • Patients with less than 6 weeks follow-up
- • Patients with incomplete medical records
- • Patients with Worker's Compensation Cases
- • Any patient with a history of infection of the ankle predating the ankle repair
- • Any orthopedic issue outside of the ankle that the Investigator feels may impede functional endpoint outcome measures.
- • Patients who have a medical history that would likely make the patient an unreliable research participant
About Stryker Trauma And Extremities
Stryker Trauma and Extremities is a leading medical technology company dedicated to advancing innovative solutions for the treatment of trauma and orthopedic conditions. With a strong focus on research and development, Stryker is committed to improving patient outcomes through cutting-edge products and comprehensive clinical trials. The company leverages its expertise in trauma and extremity surgery to deliver safe, effective, and minimally invasive solutions that enhance surgical efficiency and promote rapid recovery. By collaborating with healthcare professionals and leveraging data-driven insights, Stryker Trauma and Extremities aims to set new standards in the field of musculoskeletal care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chattanooga, Tennessee, United States
Phoenix, Arizona, United States
Kansas City, Kansas, United States
Ocean City, New Jersey, United States
Patients applied
Trial Officials
Rebecca Gibson
Study Director
Stryker Trauma & Extremities
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported